{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T06:26:27Z","timestamp":1790490387597,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T00:00:00Z","timestamp":1602547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T00:00:00Z","timestamp":1602547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["20ek0109442h0001"],"award-info":[{"award-number":["20ek0109442h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["18K07861"],"award-info":[{"award-number":["18K07861"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Dystrophin Dp71 is the smallest isoform of the <jats:italic>DMD<\/jats:italic> gene, mutations in which cause Duchenne muscular dystrophy (DMD). Dp71 has also been shown to have roles in various cellular processes. Stem cell-based therapy may be effective in treating DMD, but the inability to generate a sufficient number of stem cells remains a significant obstacle. Although Dp71 is comprised of many variants, Dp71 in satellite cells has not yet been studied. Here, the full-length Dp71 consisting of 18 exons from exons G1 to 79 was amplified by reverse transcription-PCR from total RNA of human satellite cells. The amplified product showed deletion of both exons 71 and 78 in all sequenced clones, indicating monoclonal expression of Dp71ab. Western blotting of the satellite cell lysate showed a band corresponding to over-expressed Dp71ab. Transfection of a plasmid expressing Dp71ab into human myoblasts significantly enhanced cell proliferation when compared to the cells transfected with the mock plasmid. However, transfection of the Dp71 expression plasmid encoding all 18 exons did not enhance myoblast proliferation. These findings indicated that Dp71ab, but not Dp71, is a molecular enhancer of myoblast proliferation and that transfection with Dp71ab may generate a high yield of stem cells for DMD treatment.<\/jats:p>","DOI":"10.1038\/s41598-020-74157-y","type":"journal-article","created":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T10:05:00Z","timestamp":1602583500000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Dystrophin Dp71ab is monoclonally expressed in human satellite cells and enhances proliferation of myoblast cells"],"prefix":"10.1038","volume":"10","author":[{"given":"Manal","family":"Farea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul Qawee Mahyoob","family":"Rani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Maeta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisahide","family":"Nishio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,13]]},"reference":[{"key":"74157_CR1","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/S1474-4422(03)00585-4","volume":"2","author":"F Muntoni","year":"2003","unstructured":"Muntoni, F., Torelli, S. & Ferlini, A. Dystrophin and mutations: One gene, several proteins, multiple phenotypes. Lancet Neurol. 2, 731\u2013740 (2003).","journal-title":"Lancet Neurol."},{"key":"74157_CR2","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/ng0493-283","volume":"3","author":"AH Ahn","year":"1993","unstructured":"Ahn, A. H. & Kunkel, L. M. The structural and functional diversity of dystrophin. Nat. Genet. 3, 283\u2013291 (1993).","journal-title":"Nat. Genet."},{"key":"74157_CR3","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13395-015-0062-6","volume":"5","author":"E Massourides","year":"2015","unstructured":"Massourides, E. et al. Dp412e: A novel human embryonic dystrophin isoform induced by BMP4 in early differentiated cells. Skelet. Muscle 5, 40. https:\/\/doi.org\/10.1186\/s13395-015-0062-6 (2015).","journal-title":"Skelet. Muscle"},{"key":"74157_CR4","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1042\/bj2720557","volume":"272","author":"S Bar","year":"1990","unstructured":"Bar, S. et al. A novel product of the Duchenne muscular dystrophy gene which greatly differs from the known isoforms in its structure and tissue distribution. Biochem. J. 272, 557\u2013560 (1990).","journal-title":"Biochem. J."},{"key":"74157_CR5","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.1432-0436.1992.tb00666.x","volume":"49","author":"D Rapaport","year":"1992","unstructured":"Rapaport, D. et al. Characterization and cell type distribution of a novel, major transcript of the Duchenne muscular dystrophy gene. Differentiation 49, 187\u2013193 (1992).","journal-title":"Differentiation"},{"key":"74157_CR6","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s12035-011-8218-9","volume":"45","author":"R Tadayoni","year":"2012","unstructured":"Tadayoni, R., Rendon, A., Soria-Jasso, L. E. & Cisneros, B. Dystrophin Dp71: The smallest but multifunctional product of the Duchenne muscular dystrophy gene. Mol. Neurobiol. 45, 43\u201360 (2012).","journal-title":"Mol. Neurobiol."},{"key":"74157_CR7","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1007\/s12035-017-0405-x","volume":"55","author":"J Aragon","year":"2018","unstructured":"Aragon, J. et al. Dystrophin Dp71 isoforms are differentially expressed in the mouse brain and retina: Report of new alternative splicing and a novel nomenclature for Dp71 isoforms. Mol. Neurobiol. 55, 1376\u20131386 (2018).","journal-title":"Mol. Neurobiol."},{"key":"74157_CR8","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.bbrc.2018.11.168","volume":"508","author":"AQM Rani","year":"2019","unstructured":"Rani, A. Q. M. et al. Identification of the shortest splice variant of Dp71, together with five known variants, in glioblastoma cells. Biochem. Biophys. Res. Commun. 508, 640\u2013645 (2019).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"74157_CR9","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0306-4522(03)00063-0","volume":"118","author":"FG Marquez","year":"2003","unstructured":"Marquez, F. G. et al. Differential expression and subcellular distribution of dystrophin Dp71 isoforms during differentiation process. Neuroscience 118, 957\u2013966 (2003).","journal-title":"Neuroscience"},{"key":"74157_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/hmg\/8.1.1","volume":"8","author":"R Sarig","year":"1999","unstructured":"Sarig, R. et al. Targeted inactivation of Dp71, the major non-muscle product of the DMD gene: Differential activity of the Dp71 promoter during development. Hum. Mol. Genet. 8, 1\u201310 (1999).","journal-title":"Hum. Mol. Genet."},{"key":"74157_CR11","doi-asserted-by":"publisher","first-page":"e23504","DOI":"10.1371\/journal.pone.0023504","volume":"6","author":"M Villarreal-Silva","year":"2011","unstructured":"Villarreal-Silva, M., Centeno-Cruz, F., Suarez-Sanchez, R., Garrido, E. & Cisneros, B. Knockdown of dystrophin Dp71 impairs PC12 cells cycle: Localization in the spindle and cytokinesis structures implies a role for Dp71 in cell division. PLoS ONE 6, e23504. https:\/\/doi.org\/10.1371\/journal.pone.0023504 (2011).","journal-title":"PLoS ONE"},{"key":"74157_CR12","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1078\/0065-1281-00654","volume":"104","author":"CG Garcia-Tovar","year":"2002","unstructured":"Garcia-Tovar, C. G. et al. Dystrophin isoform Dp7l is present in lamellipodia and focal complexes in human astrocytoma cells U-373 MG. Acta Histochem. 104, 245\u2013254 (2002).","journal-title":"Acta Histochem."},{"key":"74157_CR13","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3109\/07357907.2015.1084002","volume":"34","author":"S Tan","year":"2016","unstructured":"Tan, S. et al. Knocking down Dp71 expression in A549 cells reduces its malignancy in vivo and in vitro. Cancer Investig. 34, 16\u201325 (2016).","journal-title":"Cancer Investig."},{"key":"74157_CR14","doi-asserted-by":"publisher","first-page":"53702","DOI":"10.18632\/oncotarget.10724","volume":"7","author":"S Tan","year":"2016","unstructured":"Tan, S. et al. Decreased Dp71 expression is associated with gastric adenocarcinoma prognosis. Oncotarget 7, 53702\u201353711. https:\/\/doi.org\/10.18632\/oncotarget.10724 (2016).","journal-title":"Oncotarget"},{"key":"74157_CR15","doi-asserted-by":"publisher","first-page":"922","DOI":"10.3390\/cancers11070922","volume":"11","author":"O Mauduit","year":"2019","unstructured":"Mauduit, O. et al. Recurrent DMD deletions highlight specific role of Dp71 isoform in soft-tissue sarcomas. Cancers 11, 922. https:\/\/doi.org\/10.3390\/cancers11070922 (2019).","journal-title":"Cancers"},{"key":"74157_CR16","doi-asserted-by":"publisher","first-page":"5429","DOI":"10.3390\/ijms20215429","volume":"20","author":"S Ruggieri","year":"2019","unstructured":"Ruggieri, S. et al. Dp71 expression in human glioblastoma. Int. J. Mol. Sci. 20, 5429. https:\/\/doi.org\/10.3390\/ijms20215429 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"74157_CR17","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1111\/j.1471-4159.2011.07347.x","volume":"119","author":"J Aragon","year":"2011","unstructured":"Aragon, J. et al. Characterization of Dp71\u0394(78\u201379), a novel dystrophin mutant that stimulates PC12 cell differentiation. J. Neurochem. 119, 697\u2013707 (2011).","journal-title":"J. Neurochem."},{"key":"74157_CR18","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.bbrc.2008.07.135","volume":"375","author":"R Rodriguez-Munoz","year":"2008","unstructured":"Rodriguez-Munoz, R. et al. Neuronal differentiation modulates the dystrophin Dp71d binding to the nuclear matrix. Biochem. Biophys. Res. Commun. 375, 303\u2013307 (2008).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"74157_CR19","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1097\/WNR.0000000000000475","volume":"27","author":"A Herrera-Salazar","year":"2016","unstructured":"Herrera-Salazar, A. et al. Overexpression of mutant dystrophin Dp71[INCREMENT]78\u201379 stimulates cell proliferation. NeuroReport 27, 6\u201311 (2016).","journal-title":"NeuroReport"},{"key":"74157_CR20","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s12031-015-0657-8","volume":"58","author":"J Aragon","year":"2016","unstructured":"Aragon, J. et al. Identification of Dp71 isoforms expressed in PC12 cells: Subcellular localization and colocalization with \u03b2-dystroglycan and \u03b1-syntrophin. J. Mol. Neurosci. 58, 201\u2013209 (2016).","journal-title":"J. Mol. Neurosci."},{"key":"74157_CR21","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s00418-016-1439-2","volume":"146","author":"A Nishida","year":"2016","unstructured":"Nishida, A. et al. HEK293 cells express dystrophin Dp71 with nucleus-specific localization of Dp71ab. Histochem. Cell Biol. 146, 301\u2013309 (2016).","journal-title":"Histochem. Cell Biol."},{"key":"74157_CR22","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S1474-4422(09)70271-6","volume":"9","author":"K Bushby","year":"2010","unstructured":"Bushby, K. et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: Diagnosis, and pharmacological and psychosocial management. Lancet Neurol. 9, 77\u201393 (2010).","journal-title":"Lancet Neurol."},{"key":"74157_CR23","doi-asserted-by":"publisher","first-page":"113086","DOI":"10.1016\/j.expneurol.2019.113086","volume":"323","author":"C Sun","year":"2020","unstructured":"Sun, C., Serra, C., Lee, G. & Wagner, K. R. Stem cell-based therapies for Duchenne muscular dystrophy. Exp. Neurol. 323, 113086. https:\/\/doi.org\/10.1016\/j.expneurol.2019.113086 (2020).","journal-title":"Exp. Neurol."},{"key":"74157_CR24","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.molmed.2016.04.002","volume":"22","author":"NC Chang","year":"2016","unstructured":"Chang, N. C., Chevalier, F. P. & Rudnicki, M. A. Satellite cells in muscular dystrophy\u2014lost in polarity. Trends Mol. Med. 22, 479\u2013496 (2016).","journal-title":"Trends Mol. Med."},{"key":"74157_CR25","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/BF01233096","volume":"16","author":"C Webster","year":"1990","unstructured":"Webster, C. & Blau, H. M. Accelerated age-related decline in replicative life-span of Duchenne muscular dystrophy myoblasts: Implications for cell and gene therapy. Somat. Cell Mol. Genet. 16, 557\u2013565 (1990).","journal-title":"Somat. Cell Mol. Genet."},{"key":"74157_CR26","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.cell.2010.11.039","volume":"143","author":"A Sacco","year":"2010","unstructured":"Sacco, A. et al. Short telomeres and stem cell exhaustion model Duchenne muscular dystrophy in mdx\/mTR mice. Cell 143, 1059\u20131071 (2010).","journal-title":"Cell"},{"key":"74157_CR27","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1242\/dev.114223","volume":"142","author":"NA Dumont","year":"2015","unstructured":"Dumont, N. A., Wang, Y. X. & Rudnicki, M. A. Intrinsic and extrinsic mechanisms regulating satellite cell function. Development 142, 1572\u20131581 (2015).","journal-title":"Development"},{"key":"74157_CR28","doi-asserted-by":"publisher","first-page":"4251","DOI":"10.1111\/febs.12083","volume":"280","author":"M Meregalli","year":"2013","unstructured":"Meregalli, M. et al. Perspectives of stem cell therapy in Duchenne muscular dystrophy. FEBS J. 280, 4251\u20134262 (2013).","journal-title":"FEBS J."},{"key":"74157_CR29","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s12015-012-9352-0","volume":"8","author":"A Aziz","year":"2012","unstructured":"Aziz, A., Sebastian, S. & Dilworth, F. J. The origin and fate of muscle satellite cells. Stem Cell Rev. Rep. 8, 609\u2013622 (2012).","journal-title":"Stem Cell Rev. Rep."},{"key":"74157_CR30","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1093\/hmg\/4.9.1475","volume":"4","author":"RC Austin","year":"1995","unstructured":"Austin, R. C., Howard, P. L., D\u2019Souza, V. N., Klamut, H. J. & Ray, P. N. Cloning and characterization of alternatively spliced isoforms of Dp71. Hum. Mol. Genet. 4, 1475\u20131483 (1995).","journal-title":"Hum. Mol. Genet."},{"key":"74157_CR31","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/jcb.21281","volume":"102","author":"J Romo-Yanez","year":"2007","unstructured":"Romo-Yanez, J. et al. Dp71ab\/DAPs complex composition changes during the differentiation process in PC12 cells. J. Cell. Biochem. 102, 82\u201397 (2007).","journal-title":"J. Cell. Biochem."},{"key":"74157_CR32","doi-asserted-by":"publisher","first-page":"7205","DOI":"10.1038\/ncomms8205","volume":"6","author":"F Rau","year":"2015","unstructured":"Rau, F. et al. Abnormal splicing switch of DMD\u2019s penultimate exon compromises muscle fibre maintenance in myotonic dystrophy. Nat. Commun. 6, 7205. https:\/\/doi.org\/10.1038\/ncomms8205 (2015).","journal-title":"Nat. Commun."},{"key":"74157_CR33","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1172\/JCI117693","volume":"95","author":"Y Takeshima","year":"1995","unstructured":"Takeshima, Y., Nishio, H., Sakamoto, H., Nakamura, H. & Matsuo, M. Modulation of in vitro splicing of the upstream intron by modifying an intra-exon sequence which is deleted from the dystrophin gene in dystrophin Kobe. J. Clin. Investig. 95, 515\u2013520 (1995).","journal-title":"J. Clin. Investig."},{"key":"74157_CR34","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.braindev.2015.05.014","volume":"38","author":"M Matsuo","year":"2016","unstructured":"Matsuo, M., Takeshima, Y. & Nishio, H. Contributions of Japanese patients to development of antisense therapy for DMD. Brain Dev. 38, 4\u20139 (2016).","journal-title":"Brain Dev."},{"key":"74157_CR35","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ymgme.2016.04.001","volume":"118","author":"MC Miceli","year":"2016","unstructured":"Miceli, M. C. & Nelson, S. F. The case for eteplirsen: Paving the way for precision medicine. Mol. Genet. Metab. 118, 70\u201371 (2016).","journal-title":"Mol. Genet. Metab."},{"key":"74157_CR36","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.3390\/cells8091066","volume":"8","author":"N Motohashi","year":"2019","unstructured":"Motohashi, N., Shimizu-Motohashi, Y., Roberts, T. C. & Aoki, Y. Potential therapies using myogenic stem cells combined with bio-engineering approaches for treatment of muscular dystrophies. Cells 8, 1066. https:\/\/doi.org\/10.3390\/cells8091066 (2019).","journal-title":"Cells"},{"key":"74157_CR37","doi-asserted-by":"publisher","first-page":"e0188821","DOI":"10.1371\/journal.pone.0188821","volume":"12","author":"Y Nagata","year":"2017","unstructured":"Nagata, Y. et al. Interleukin-1beta (IL-1\u03b2)-induced notch ligand Jagged1 suppresses mitogenic action of IL-1\u03b2 on human dystrophic myogenic cells. PLoS ONE 12, e0188821. https:\/\/doi.org\/10.1371\/journal.pone.0188821 (2017).","journal-title":"PLoS ONE"},{"key":"74157_CR38","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/ncomms1306","volume":"2","author":"A Nishida","year":"2011","unstructured":"Nishida, A. et al. Chemical treatment enhances skipping of a mutated exon in the dystrophin gene. Nat. Commun. 2, 308. https:\/\/doi.org\/10.1038\/ncomms1306 (2011).","journal-title":"Nat. Commun."},{"key":"74157_CR39","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.ymgme.2005.03.006","volume":"85","author":"HT Thi Tran","year":"2005","unstructured":"Thi Tran, H. T. et al. A G-to-A transition at the fifth position of intron 32 of the dystrophin gene inactivates a splice donor site both in vivo and in vitro. Mol. Genet. Metab. 85, 213\u2013219 (2005).","journal-title":"Mol. Genet. Metab."},{"key":"74157_CR40","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.3390\/ijms19061546","volume":"19","author":"T Kawaguchi","year":"2018","unstructured":"Kawaguchi, T. et al. Detection of dystrophin Dp71 in human skeletal muscle using an automated capillary western assay system. Int. J. Mol. Sci. 19, 1546. https:\/\/doi.org\/10.3390\/ijms19061546 (2018).","journal-title":"Int. J. Mol. Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-74157-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-74157-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-74157-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T21:23:57Z","timestamp":1670361837000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-74157-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,13]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["74157"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-74157-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,13]]},"assertion":[{"value":"27 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"MM is an advisor to JCR Pharma Co., Ltd., Japan and Daiichi Sankyo Co., Ltd., Japan. KM is employed by KNC Laboratories Co., Ltd., Japan. The other authors declare that they have no competing interests. The study sponsors played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the manuscript for publication.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17123"}}